These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 25880400)

  • 21. Multimodal brain imaging connectivity analyses of emotional and motivational deficits in depression among women.
    Robert G; Bannier E; Comte M; Domain L; Corouge I; Dondaine T; Batail JM; Ferre JC; Fakra E; Drapier D
    J Psychiatry Neurosci; 2021 Apr; 46(2):E303-E312. PubMed ID: 33844485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duloxetine effects on striatal resting-state functional connectivity in patients with major depressive disorder.
    Wang L; An J; Gao HM; Zhang P; Chen C; Li K; Mitchell PB; Si TM
    Hum Brain Mapp; 2019 Aug; 40(11):3338-3346. PubMed ID: 31066977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neural responses to happy facial expressions in major depression following antidepressant treatment.
    Fu CH; Williams SC; Brammer MJ; Suckling J; Kim J; Cleare AJ; Walsh ND; Mitterschiffthaler MT; Andrew CM; Pich EM; Bullmore ET
    Am J Psychiatry; 2007 Apr; 164(4):599-607. PubMed ID: 17403973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of 12-week escitalopram treatment on resting-state functional connectivity of large-scale brain networks in major depressive disorder.
    Zhang S; Zhou J; Cui J; Zhang Z; Liu R; Feng Y; Feng L; Wang Y; Chen X; Wu H; Jin Y; Zhou Y; Wang G
    Hum Brain Mapp; 2023 Apr; 44(6):2572-2584. PubMed ID: 36773284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neural Correlates of Antidepressant Treatment Response in Adolescents with Major Depressive Disorder.
    Cullen KR; Klimes-Dougan B; Vu DP; Westlund Schreiner M; Mueller BA; Eberly LE; Camchong J; Westervelt A; Lim KO
    J Child Adolesc Psychopharmacol; 2016 Oct; 26(8):705-712. PubMed ID: 27159204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Perahia DG; Wang F; Mallinckrodt CH; Walker DJ; Detke MJ
    Eur Psychiatry; 2006 Sep; 21(6):367-78. PubMed ID: 16697153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of duloxetine treatment on brain response to painful stimulation in major depressive disorder.
    López-Solà M; Pujol J; Hernández-Ribas R; Harrison BJ; Contreras-Rodríguez O; Soriano-Mas C; Deus J; Ortiz H; Menchón JM; Vallejo J; Cardoner N
    Neuropsychopharmacology; 2010 Oct; 35(11):2305-17. PubMed ID: 20668437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apathy in currently nondepressed patients treated with a SSRI for a major depressive episode: outcomes following randomized switch to either duloxetine or escitalopram.
    Raskin J; George T; Granger RE; Hussain N; Zhao GW; Marangell LB
    J Psychiatr Res; 2012 May; 46(5):667-74. PubMed ID: 22410206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.
    Nierenberg AA; Greist JH; Mallinckrodt CH; Prakash A; Sambunaris A; Tollefson GD; Wohlreich MM
    Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study.
    Fu CH; Williams SC; Cleare AJ; Brammer MJ; Walsh ND; Kim J; Andrew CM; Pich EM; Williams PM; Reed LJ; Mitterschiffthaler MT; Suckling J; Bullmore ET
    Arch Gen Psychiatry; 2004 Sep; 61(9):877-89. PubMed ID: 15351766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emotion-Dependent Functional Connectivity of the Default Mode Network in Adolescent Depression.
    Ho TC; Connolly CG; Henje Blom E; LeWinn KZ; Strigo IA; Paulus MP; Frank G; Max JE; Wu J; Chan M; Tapert SF; Simmons AN; Yang TT
    Biol Psychiatry; 2015 Nov; 78(9):635-46. PubMed ID: 25483399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional default mode network connectivity in major depressive disorder: modulation by acute intravenous citalopram.
    Dutta A; McKie S; Downey D; Thomas E; Juhasz G; Arnone D; Elliott R; Williams S; Deakin JFW; Anderson IM
    Transl Psychiatry; 2019 Mar; 9(1):116. PubMed ID: 30877271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occupancy of serotonin transporters in the amygdala by paroxetine in association with attenuation of left amygdala activation by negative faces in major depressive disorder.
    Ruhé HG; Koster M; Booij J; van Herk M; Veltman DJ; Schene AH
    Psychiatry Res; 2014 Feb; 221(2):155-61. PubMed ID: 24406081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women.
    Kennedy SE; Koeppe RA; Young EA; Zubieta JK
    Arch Gen Psychiatry; 2006 Nov; 63(11):1199-208. PubMed ID: 17088500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal resting state effective connectivity within the default mode network in major depressive disorder: A spectral dynamic causal modeling study.
    Li L; Li B; Bai Y; Liu W; Wang H; Leung HC; Tian P; Zhang L; Guo F; Cui LB; Yin H; Lu H; Tan Q
    Brain Behav; 2017 Jul; 7(7):e00732. PubMed ID: 28729938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Resting state connectivity correlates with drug and placebo response in fibromyalgia patients.
    Schmidt-Wilcke T; Ichesco E; Hampson JP; Kairys A; Peltier S; Harte S; Clauw DJ; Harris RE
    Neuroimage Clin; 2014; 6():252-61. PubMed ID: 25379438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased ventromedial prefrontal cortex activity and connectivity predict poor sertraline treatment outcome in late-life depression.
    Emam H; Steffens DC; Pearlson GD; Wang L
    Int J Geriatr Psychiatry; 2019 May; 34(5):730-737. PubMed ID: 30761621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rescue pharmacotherapy with duloxetine for selective serotonin reuptake inhibitor nonresponders in late-life depression: outcome and tolerability.
    Karp JF; Whyte EM; Lenze EJ; Dew MA; Begley A; Miller MD; Reynolds CF
    J Clin Psychiatry; 2008 Mar; 69(3):457-63. PubMed ID: 18251622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cortical Connectivity Moderators of Antidepressant vs Placebo Treatment Response in Major Depressive Disorder: Secondary Analysis of a Randomized Clinical Trial.
    Rolle CE; Fonzo GA; Wu W; Toll R; Jha MK; Cooper C; Chin-Fatt C; Pizzagalli DA; Trombello JM; Deckersbach T; Fava M; Weissman MM; Trivedi MH; Etkin A
    JAMA Psychiatry; 2020 Apr; 77(4):397-408. PubMed ID: 31895437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.
    Lam RW; Lönn SL; Despiégel N
    Int Clin Psychopharmacol; 2010 Jul; 25(4):199-203. PubMed ID: 20357664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.